World Health Organization site
Skip Navigation Links
Home
Advanced Search
List ByExpand List By
Search Tips
UTNExpand UTN
ICTRP websiteExpand ICTRP website
Contact us
                   6 records for 2 trials found!
Trials are sometimes recorded in more than one registry. These records can refer to each other using the 'Secondary ID' field. The search portal uses these Secondary IDs to group records about the same trial together in the search results.
Each group of records referring to a trial is displayed in table that is seen by pressing the + symbol. The record with the earliest date of registration is always shown first.
 
 
 
 
  Showrecords per page     

1
Recruitment statusMain ID Public TitleDate of Registration
Not recruitingNCT00842101
Compartmental Overpressures Associated to Reamed Intramedullary Nails
10/02/2009
Not RecruitingEUCTR2007-006096-37-NL
A prospective, multinational, multicenter, randomized, double-blind, double-dummy, controlled study comparing the efficacy and safety of moxifloxacin to that of amoxicillin-clavulanic acid for the treatment of subjects with acute exacerbations of chronic bronchitis: MAESTRAL (moxifloxacin in AECB superiority trial) - MAESTRAL
Recruitment statusMain IDPublic titleDate of registration
Not RecruitingEUCTR2007-006096-37-GBA prospective, multinational, multicenter, randomized, double-blind, double-dummy, controlled study comparing the efficacy and safety of moxifloxacin to that of amoxicillin-clavulanic acid for the treatment of subjects with acute exacerbations of chronic bronchitis: MAESTRAL (moxifloxacin in AECB superiority trial) - MAESTRAL22/02/2008
Not RecruitingEUCTR2007-006096-37-IEA prospective, multinational, multicenter, randomized, double-blind, double-dummy, controlled study comparing the efficacy and safety of moxifloxacin to that of amoxicillin-clavulanic acid for the treatment of subjects with acute exacerbations of chronic bronchitis: MAESTRAL (moxifloxacin in AECB superiority trial) - MAESTRAL05/03/2008
Not RecruitingEUCTR2007-006096-37-PTA prospective, multinational, multicenter, randomized, double-blind, double-dummy, controlled study comparing the efficacy and safety of moxifloxacin to that of amoxicillin-clavulanic acid for the treatment of subjects with acute exacerbations of chronic bronchitis: MAESTRAL (moxifloxacin in AECB superiority trial) - MAESTRAL14/04/2008
Not RecruitingEUCTR2007-006096-37-ESEnsayo clínico prospectivo, multinacional, multicéntrico, aleatorizado, doble ciego, doble simulación, que compara la eficacia y la seguridad de moxifloxacino respecto a amoxicilina/ácido clavulánico en el tratamiento de pacientes con exacerbaciones agudas de bronquitis crónica”Estudio MAESTRAL. (A prospective, multinational, multicenter, randomized, double-blind, double-dummy, controlled study comparing the efficacy and safety of moxifloxacin to that of amoxicillin-clavulanic acid for the treatment of subjects with acute exacerbations of chronic bronchitis: MAESTRAL (moxifloxacin in AECB superiority trial) - MAESTRAL14/04/2008
Not RecruitingEUCTR2007-006096-37-GRA prospective, multinational, multicenter, randomized, double-blind, double-dummy, controlled study comparing the efficacy and safety of moxifloxacin to that of amoxicillin-clavulanic acid for the treatment of subjects with acute exacerbations of chronic bronchitis: MAESTRAL (moxifloxacin in AECB superiority trial) - MAESTRAL02/05/2008
Not RecruitingEUCTR2007-006096-37-LTA prospective, multinational, multicenter, randomized, double-blind, double-dummy, controlled study comparing the efficacy and safety of moxifloxacin to that of amoxicillin-clavulanic acid for the treatment of subjects with acute exacerbations of chronic bronchitis: MAESTRAL (moxifloxacin in AECB superiority trial) - MAESTRAL09/07/2008
Not RecruitingEUCTR2007-006096-37-ITA prospective, multinational, multicenter, randomized, double blind, double dummy, controlled study comparing the efficacy and safety of moxifloxacin to that of amoxicillin clavulanic acid for the treatment of subjects with acute exacerbations of chronic bronchitis - ''MAESTRAL'' (moxifloxacin in AECB Superiority TRiAL) - MAESTRAL15/09/2008
Not RecruitingEUCTR2007-006096-37-LVA prospective, multinational, multicenter, randomized, double-blind, double-dummy, controlled study comparing the efficacy and safety of moxifloxacin to that of amoxicillin-clavulanic acid for the treatment of subjects with acute exacerbations of chronic bronchitis: MAESTRAL (moxifloxacin in AECB superiority trial) - MAESTRAL19/08/2008
Not RecruitingEUCTR2007-006096-37-CZA prospective, multinational, multicenter, randomized, double-blind, double-dummy, controlled study comparing the efficacy and safety of moxifloxacin to that of amoxicillin-clavulanic acid for the treatment of subjects with acute exacerbations of chronic bronchitis: MAESTRAL (moxifloxacin in AECB superiority trial) - MAESTRAL25/05/2009
Not RecruitingEUCTR2007-006096-37-DEA prospective, multinational, multicenter, randomized, double-blind, double-dummy, controlled study comparing the efficacy and safety of moxifloxacin to that of amoxicillin-clavulanic acid for the treatment of subjects with acute exacerbations of chronic bronchitis: MAESTRAL (moxifloxacin in AECB superiority trial) - MAESTRAL07/04/2008
Not RecruitingEUCTR2007-006096-37-BEA prospective, multinational, multicenter, randomized, double-blind, double-dummy, controlled study comparing the efficacy and safety of moxifloxacin to that of amoxicillin-clavulanic acid for the treatment of subjects with acute exacerbations of chronic bronchitis: MAESTRAL (moxifloxacin in AECB superiority trial) - MAESTRAL12/03/2008
Not recruitingNCT00656747Moxifloxacin Versus Amoxicillin Clavulanic Acid in Treatment of Acute Exacerbation of Chronic Bronchitis04/04/2008
01/02/2008
Not RecruitingEUCTR2006-004495-13-BE
Oral direct factor Xa inhibitor rivaroxaban in patients with acute symptomatic deep-vein thrombosis or pulmonary embolism.
Recruitment statusMain IDPublic titleDate of registration
AuthorisedEUCTR2006-004495-13-ESOral direct factor Xa inhibitor rivaroxaban in patients with acute symptomatic deep-vein thrombosis or pulmonary embolism. Rivaroxaban oral, inhibidor directo del factor Xa en pacientes con trombosis venosa profunda o embolia pulmonar agudas sintomáticas.26/01/2007
AuthorisedEUCTR2006-004495-13-FROral direct factor Xa inhibitor rivaroxaban in patients with acute symptomatic deep-vein thrombosis or pulmonary embolism.15/02/2007
Not RecruitingEUCTR2006-004495-13-SEOral direct factor Xa inhibitor rivaroxaban in patients with acute symptomatic deep-vein thrombosis or pulmonary embolism.06/02/2007
Not RecruitingEUCTR2006-004495-13-FIOral direct factor Xa inhibitor rivaroxaban in patients with acute symptomatic deep-vein thrombosis or pulmonary embolism.22/02/2007
Not RecruitingEUCTR2006-004495-13-HUOral direct factor Xa inhibitor rivaroxaban in patients with acute symptomatic deep-vein thrombosis or pulmonary embolism.03/04/2007
Not RecruitingEUCTR2006-004495-13-DKOral direct factor Xa inhibitor rivaroxaban in patients with acute symptomatic deep-vein thrombosis or pulmonary embolism.29/03/2007
Not RecruitingEUCTR2006-004495-13-ITOral direct factor Xa inhibitor rivaroxaban in patients with acute symptomatic deep-vein thrombosis or pulmonary embolism. - ''Einstein''02/05/2007
Not RecruitingEUCTR2006-004495-13-ATOral direct factor Xa inhibitor rivaroxaban in patients with acute symptomatic deep-vein thrombosis or pulmonary embolism.16/04/2007
AuthorisedEUCTR2006-004495-13-GBOral direct factor Xa inhibitor rivaroxaban in patients with acute symptomatic deep-vein thrombosis or pulmonary embolism. - The Einstein Study15/05/2007
Not RecruitingEUCTR2006-004495-13-LTOral direct factor Xa inhibitor rivaroxaban in patients with acute symptomatic deep-vein thrombosis or pulmonary embolism.05/02/2010
Not RecruitingEUCTR2006-004495-13-EEOral direct factor Xa inhibitor rivaroxaban in patients with acute symptomatic deep-vein thrombosis or pulmonary embolism.10/02/2010
Not RecruitingEUCTR2006-004495-13-LVOral direct factor Xa inhibitor rivaroxaban in patients with acute symptomatic deep-vein thrombosis or pulmonary embolism.24/02/2010
Not RecruitingEUCTR2006-004495-13-NLOral direct factor Xa inhibitor rivaroxaban in patients with acute symptomatic deep-vein thrombosis or pulmonary embolism.14/06/2007
Not RecruitingEUCTR2006-004495-13-DEOral direct factor Xa inhibitor rivaroxaban in patients with acute symptomatic deep-vein thrombosis or pulmonary embolism.20/02/2007
Not RecruitingEUCTR2006-004495-13-IEOral direct factor Xa inhibitor rivaroxaban in patients with acute symptomatic deep-vein thrombosis or pulmonary embolism.21/01/2010
Not recruitingNCT00439777Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients With Acute Symptomatic Pulmonary Embolism - The EINSTEIN PE Study23/02/2007
Not recruitingNCT00440193Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients With Acute Symptomatic Deep Vein Thrombosis - The EINSTEIN DVT Study23/02/2007
Not RecruitingCTRI/2007/091/000024Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients With Acute Symptomatic Deep-Vein Thrombosis or Pulmonary Embolism22-09-2008
18/12/2006
Not recruitingNCT00363896
A Trial Assessing LAS34273 in Moderate to Severe Stable Chronic Obstructive Pulmonary Disease (COPD)
10/08/2006
AuthorisedEUCTR2004-000404-40-IE
A double-blind, randomised, placebo controlled study to investigate chronic intermittent “pulse” therapy of moxifloxacin as a prevention of acute exacerbation in out-patients with chronic bronchitis. - PULSE 11/08/2004
    
1
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.2 - Version history